Abstract
Positron emission tomography (PET) with 11C-2-deoxyglucose (11DG) was used to compare regional brain metabolism in four patients with chronic schizophrenia who had no history of psychotropic medication and in 12 normal controls. Patients had a second PET scan after an injection of thiothixene to evaluate the effects of acute neuroleptics on glucose metabolism. The patients showed higher glucose metabolic values than the normals and did not show the metabolic hypofrontality reported in chronic medicated patients with schizophrenia. Administration of the neuroleptic did not have a significant effect in the metabolic pattern of the patients. These results give support to the hypothesis that prolonged medication may contribute to the metabolic hypofrontal pattern seen in patients with schizophrenia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Buchsbaum M. S., Ingvar D. H., Kessler R., Waters R. N., Cappelletti J., van Kammen D. P., King A. C., Johnson J. L., Manning R. G., Flynn R. W. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry. 1982 Mar;39(3):251–259. doi: 10.1001/archpsyc.1982.04290030001001. [DOI] [PubMed] [Google Scholar]
- Farkas T., Wolf A. P., Jaeger J., Brodie J. D., Christman D. R., Fowler J. S. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch Gen Psychiatry. 1984 Mar;41(3):293–300. doi: 10.1001/archpsyc.1984.01790140083010. [DOI] [PubMed] [Google Scholar]
- Horwitz B., Duara R., Rapoport S. I. Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input. J Cereb Blood Flow Metab. 1984 Dec;4(4):484–499. doi: 10.1038/jcbfm.1984.73. [DOI] [PubMed] [Google Scholar]
- Lidsky T. I., Weinhold P. M., Levine F. M. Implications of basal ganglionic dysfunction for schizophrenia. Biol Psychiatry. 1979 Feb;14(1):3–12. [PubMed] [Google Scholar]
- METTLER F. A. Perceptual capacity, functions of the corpus striatum and schizophrenia. Psychiatr Q. 1955;29(1):89–111. doi: 10.1007/BF01567442. [DOI] [PubMed] [Google Scholar]
- Mazziotta J. C., Phelps M. E., Plummer D., Kuhl D. E. Quantitation in positron emission computed tomography: 5. Physical--anatomical effects. J Comput Assist Tomogr. 1981 Oct;5(5):734–743. doi: 10.1097/00004728-198110000-00029. [DOI] [PubMed] [Google Scholar]
- McCulloch J., Savaki H. E., Sokoloff L. Distribution of effects of haloperidol on energy metabolism in the rat brain. Brain Res. 1982 Jul 8;243(1):81–90. doi: 10.1016/0006-8993(82)91122-2. [DOI] [PubMed] [Google Scholar]
- Pizzolato G., Soncrant T. T., Rapoport S. I. Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics. J Neurochem. 1984 Sep;43(3):724–732. doi: 10.1111/j.1471-4159.1984.tb12792.x. [DOI] [PubMed] [Google Scholar]
- Reivich M., Alavi A., Wolf A., Greenberg J. H., Fowler J., Christman D., MacGregor R., Jones S. C., London J., Shiue C. Use of 2-deoxy-D[1-11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects. J Cereb Blood Flow Metab. 1982 Sep;2(3):307–319. doi: 10.1038/jcbfm.1982.32. [DOI] [PubMed] [Google Scholar]
- Widen L., Blomqvist G., Greitz T., Litton J. E., Bergström M., Ehrin E., Ericson K., Eriksson L., Ingvar D. H., Johansson L. PET studies of glucose metabolism in patients with schizophrenia. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):550–552. [PMC free article] [PubMed] [Google Scholar]
- Wolkin A., Jaeger J., Brodie J. D., Wolf A. P., Fowler J., Rotrosen J., Gomez-Mont F., Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry. 1985 May;142(5):564–571. doi: 10.1176/ajp.142.5.564. [DOI] [PubMed] [Google Scholar]